Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Regulatory News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.00
Bid: 68.00
Ask: 70.00
Change: 0.00 (0.00%)
Spread: 2.00 (2.941%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 69.00
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors Dealing Notification

18 Apr 2018 17:08

RNS Number : 3812L
NetScientific PLC
18 April 2018
 

18 April 2018

NetScientific plc

 

Directors Dealing Notification

 

NetScientific plc (AIM:NSCI) (the "Company"), the transatlantic healthcare IP commercialisation group, announces that on 17 April 2018 it received notification that Sir Richard Sykes, Barry Wilson, and Steve Smith (the "Directors"), subscribed for New Ordinary Shares (the "Shares") in the NetScientific Placing and Subscription (the "Placing") at a price of 52.5 pence per Share, with the Shares admitted to trading on AIM on 17 April 2018.

 

The details of the Directors' shareholdings in the Company following the Placing are as follows:

 

 

No. of Ordinary Shares as at 28 March 2018

(date of announcement of conditional Placing)

No. of New Ordinary Shares subscribed

No. of Ordinary Shares as at Admission

Percentage of enlarged share capital as at Admission

Sir Richard Sykes

62,500

30,952

93,452

0.12%

Barry Wilson

36,358

30,952

67,310

0.09%

Professor Stephen Smith

-

28,571

28,571

0.04%

 

The total number of voting rights in NetScientific is 78,561,866.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 Details of the person discharging managerial responsibility / person closely associated 

 

a)

 

 Name

 

 Sir Richard Sykes

2

 Reason for the notification

 

a)

 

 Position/status

 

 PDMR (Non-Executive Director - Chairman)

 

b)

 

 Initial notification/amendment

 

 Initial notification

3

 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 NetScientific plc

 

b)

 

LEI

 

 213800N5WD46G1Y7I458

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

 Ordinary shares

 

Identification code

 

 GB00B9F4MT28

 

b)

 

Nature of transaction

 

 Participation in placing

 

c)

 

 Price(s) and volume(s)

 

 Price(s)

 

 Volume(s)

 

 £0.525 per share

 

 30,952

 

d)

 

Aggregated information

 

Aggregated volume

 

 30,952

 

Price

 

 £0.525 per share

 

e)

 

Date of transaction

 

 17 April 2018

 

f)

 

Place of transaction

 

 UK AIM

 

 

1

 Details of the person discharging managerial responsibility / person closely associated 

 

a)

 

 Name

 

 Barry Wilson

2

 Reason for the notification

 

a)

 

 Position/status

 

 PDMR (Non-Executive Director)

 

b)

 

 Initial notification/amendment

 

 Initial notification

3

 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 NetScientific plc

 

b)

 

LEI

 

 213800N5WD46G1Y7I458

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

 Ordinary shares

 

Identification code

 

 GB00B9F4MT28

 

b)

 

Nature of transaction

 

 Participation in placing

 

c)

 

 Price(s) and volume(s)

 

 Price(s)

 

 Volume(s)

 

 £0.525 per share

 

 30,952

 

d)

 

Aggregated information

 

Aggregated volume

 

 30,952

 

Price

 

 £0.525 per share

 

e)

 

Date of transaction

 

 17 April 2018

 

f)

 

Place of transaction

 

 UK AIM

 

 

1

 Details of the person discharging managerial responsibility / person closely associated 

 

a)

 

 Name

 

 Steve Smith

2

 Reason for the notification

 

a)

 

 Position/status

 

 PDMR (Non-Executive Director)

 

b)

 

 Initial notification/amendment

 

 Initial notification

3

 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 NetScientific plc

 

b)

 

LEI

 

 213800N5WD46G1Y7I458

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

 Ordinary shares

 

Identification code

 

 GB00B9F4MT28

 

b)

 

Nature of transaction

 

 Participation in placing

 

c)

 

 Price(s) and volume(s)

 

 Price(s)

 

 Volume(s)

 

 £0.525 per share

 

 28,571

 

d)

 

Aggregated information

 

Aggregated volume

 

 28,571

 

Price

 

 £0.525 per share

 

e)

 

Date of transaction

 

 17 April 2018

 

f)

 

Place of transaction

 

 UK AIM

 

 

For more information, please contact:

 

NetScientific plc

François R. Martelet, M.D., CEO

Ian Postlethwaite, CFO

Tel: +44 (0)20 3514 1800

Consilium Strategic Communications

Mary-Jane Elliott/Jessica Hodgson

Chris Welsh/Laura Thornton

Tel: +44 (0)20 3709 5700

netscientific@consilium-comms.com

Stifel Nicolaus Europe Limited (NOMAD and Bookrunner)

Jonathan Senior/David Arch/Ben Maddison

 Tel: +44 (0) 20 7710 7600

Liberum Capital Limited (Placing Agent)

David Parsons/Christopher Britton/Bidhi Bhoma/Euan Brown

Tel: +44 (0)20 3709 5700

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGGUAUCUPRGQR
Date   Source Headline
21st Dec 201811:04 amRNSForm 8.5 - NetScientific PLC
20th Dec 20184:41 pmRNSSecond Price Monitoring Extn
20th Dec 20184:36 pmRNSPrice Monitoring Extension
20th Dec 201810:28 amRNSForm 8.5 - NetScientific PLC
20th Dec 20187:00 amRNSUpdate on Strategic Review
19th Dec 201811:03 amRNSForm 8.3 - NetScientific Plc
19th Dec 201811:00 amRNSForm 8.3 - NetScientific plc
19th Dec 20189:34 amRNSForm 8.5 - NetScientific PLC
18th Dec 20189:32 amRNSForm 8.5 - NetScientific PLC
13th Dec 20189:06 amRNSForm 8.5 - NetScientific PLC
7th Dec 201810:23 amRNSForm 8.5 - NetScientific PLC
5th Dec 20189:14 amRNSForm 8.5 - NetScientific PLC
4th Dec 20189:50 amRNSForm 8.5 - NetScientific PLC
3rd Dec 201810:31 amRNSForm 8.5 - NetScientific PLC
30th Nov 20183:46 pmRNSForm 8 (OPD) - NetScientific (Offeree)
30th Nov 201811:35 amRNSForm 8.5 - NetScientific PLC
29th Nov 20181:29 pmRNSForm 8.3 - NetScientific Plc
29th Nov 201812:49 pmRNSForm 8.3 - NetScientific Plc
29th Nov 201810:26 amRNSForm 8.5 - NetScientific PLC
28th Nov 20181:46 pmRNSForm 8.3 - NetScientific Plc
28th Nov 20189:51 amRNSForm 8.5 - NetScientific PLC
27th Nov 201812:44 pmGNWInvesco Ltd.: Form 8.3 - Netscientific Plc
27th Nov 201812:34 pmRNSForm 8.3 - NetScientfic Plc
27th Nov 201810:33 amRNSForm 8.5 - NetScientific PLC
27th Nov 20189:36 amRNSForm 8.3 - NetScientific PLC
26th Nov 20183:01 pmRNSAmendment to Executive Director Service Terms
26th Nov 20183:00 pmRNSAnnouncement of Strategic Review
26th Nov 201812:30 pmRNSPDS Announces Merger with Edge Therapeutics
8th Nov 20187:00 amRNSVortex Improves CTC Enumeration with Impedance
1st Nov 20187:00 amRNSVortex and STRATEC Announce Global Partnership
22nd Oct 20181:01 pmRNSGlycotest Completes $10m Series A Round with Fosun
22nd Oct 20187:00 amRNSGlycotest Completes $10m Series A Round with Fosun
28th Sep 20187:00 amRNSInterim Results
20th Sep 20187:00 amRNSProAxsis Immunoassays Selected for Large Trial
15th Aug 20187:00 amRNSWanda Launches CareLink, New Digital Health App
2nd Aug 20187:02 amRNSProAxsis Granted Third Respiratory Field CE Mark
2nd Aug 20187:00 amRNSChange of Adviser
18th Jul 20187:00 amRNSWanda Technology Enhancements
26th Jun 20184:24 pmRNSGrant of Options to Directors
21st Jun 20181:33 pmRNSResult of AGM
6th Jun 20187:00 amRNSBob Englert Appointed CEO of Vortex Biosciences
4th Jun 20187:00 amRNSProAxsis Wins Innovative Business of Year in NI
1st Jun 20187:00 amRNSProAxsis Awarded Invest NI Grant
22nd May 20184:21 pmRNSNotice of AGM and Annual Report & Accounts
21st May 20187:00 amRNSWanda Announces Significant Data with Partner HRS
2nd May 20187:00 amRNSProAxsis to Present New Data at ATS 2018
18th Apr 20185:08 pmRNSDirectors Dealing Notification
16th Apr 20182:04 pmRNSResult of General Meeting
16th Apr 20187:25 amRNSVortex to Present 2 Posters at AACR
11th Apr 201811:39 amRNSResult of Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.